Effects of metformin plus simvastatin on polycystic ovary syndrome: A prospective, randomized, double-blind, placebo-controlled study

Fertility and Sterility

Volumn 94, Issue 6, 2010, Pages 2208-2213

  Kazerooni, Talieh ^a   Shojaei Baghini, Azam ^a   Dehbashi, Sedigheh ^a   Asadi, Nasrin ^a   Ghaffarpasand, Fariborz ^b   Kazerooni, Yasaman ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

Author keywords

lipid profile; metformin; Polycystic ovary syndrome; simvastatin; testosterone

Indexed keywords

CHOLESTEROL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; LUTEINIZING HORMONE; METFORMIN; PLACEBO; PRASTERONE SULFATE; SIMVASTATIN; TESTOSTERONE; TRIACYLGLYCEROL;

ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CHEMICAL PARAMETERS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION TEST; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MUSCLE INJURY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, HDL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LUTEINIZING HORMONE; METFORMIN; PLACEBOS; POLYCYSTIC OVARY SYNDROME; SIMVASTATIN; TESTOSTERONE; YOUNG ADULT;

EID: 77958522601     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.11.045     Document Type: Article

References (33)

1. M. Asunción, R.M. Calvo, J.L. San Millán, J. Sancho, S. Avila, and H.F. Escobar-Morreale A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain J Clin Endocrinol Metab 85 2000 2434 2438
2. E. Diamanti-Kandarakis, C.R. Kouli, A.T. Bergiele, F.A. Filandra, T.C. Tsianateli, and G.G. Spina A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile J Clin Endocrinol Metab 84 1999 4006 4011
3. R.S. Legro Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocrinol Rev 24 2003 302 312
4. E. Diamanti-Kandarakis, A.G. Papavassiliou, S.A. Kandarakis, and G.P. Chrousos Pathophysiology and types of dyslipidemia in PCOS Trends Endocrinol Metab 18 2007 280 285
5. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
6. E. Diamanti-Kandarakis, E. Kandaraki, C. Christakou, and D. Panidis The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome Obes Rev 10 2009 431 441
7. T. Kazerooni, F. Ghaffarpasand, Y. Kazerooni, M. Kazerooni, and S. Setoodeh Short-term metformin treatment for clomiphene citrate-resistant women with polycystic ovary syndrome Int J Gynecol Obstet 107 2009 50 53
8. M. Clearfield Evolution of cholesterol management therapies: exploiting potential for further improvement Am J Ther 10 2003 275 281
9. S.I. McFarlane, R. Muniyappa, R. Francisco, and J.R. Sowers Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond J Clin Endocrinol Metab 87 2002 1451 1458
10. H. Ando, T. Takamura, T. Ota, Y. Nagai, and K. Kobayashi Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis J Pharmacol Exp Ther 294 2000 1043 1046
11. S. Wassmann, U. Laufs, K. Muller, C. Konkol, K. Ahlbory, and A.T. Baumer Cellular antioxidant effects of atorvastatin in vitro and in vivo Arterioscler Thromb Vasc Biol 22 2002 300 305
12. A.J. Duleba, B. Bonaszewska, R.Z. Spaezynski, and L. Powelczyk Simvastatin improve biochemical parameters in women with polycystic ovary syndrome: results of a prospective randomize trial Fertil Steril 85 2006 996 1001
13. B. Bnaszewska, L. Pawelezyk, R. Spaczynsk, J. Dziura, and A.J. Duleba Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective randomized cross over trial Clin Endocrinol Metab 92 2007 456 461
14. D. Izquierdo, N. Foyouzi, J. Kwintkiewicz, and A.J. Duleba Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis Fertil Steril 82 Suppl 3 2004 1193 1197
15. R. Azziz, D. Dewailly, and D. Owerbach Nonclassic adrenal hyperplasia: current concepts J Clin Endocrinol Metab 78 1994 810 815
16. P.C. White, K.M. Curnow, and L. Pascoe Disorders of steroid 11β-hydroxylase isozymes Endocrinol Rev 15 1994 421 438
17. A. Katz, S.S. Nambi, K. Mather, A.D. Baron, D.A. Follmann, and G. Sullivan Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
18. R.S. Legro, D. Finegood, and A. Dunaif A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome J Clin Endocrinol Metab 83 1998 2694 2698
19. D. Ferriman, and J.D. Gallway Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447
20. E. Diamanti Kandarakis, C. Kouli, T. Tsianateli, and A. Bergiele Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome Eur J Endocrinol 138 1998 269 274
21. L.C. Morin Papunen, R.M. Koivunen, A. Ruokonen, and H.K. Martikainen Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome Fertil Steril 69 1998 691 696
22. C.J. Glueck, P. Wang, R. Fontaine, T. Tracy, and L. Sieve-Smith Metformin induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome Metabolism 48 1999 511 519
23. I. Kocak, and C. Ustan Effect of metformin on insulin resistance, androgen concentration, ovulation and pregnancy rates in women with polycystic ovary syndrome following laparoscopic ovarian drilling Fertil Steril 32 2006 292 298
24. C. Kaya, S.D. Cengiz, B. Berker, S. Demirtas, M. Cesur, and G. Erdogan Comparative effects of atrovastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study Fertil Steril 92 2009 635 642
25. J.E. Nestler, and D.J. Jakubowicz Decrease in ovarian cytochrome P450c17alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome N Engl J Med 335 1996 617 623
26. H. Ide, S. Fujiya, Y. Aanuma, and Y. Agishi Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones Clin Ther 12 1990 410 420
27. R.H. Jay, R.H. Sturley, C. Stirling, H.H. McGarrigle, M. Katz, and J.P. Reckless Effects of pravastatin and cholestyramine on gonadal and adrenal steroid production in familial hypercholesterolaemia Br J Clin Pharmacol 32 1991 417 422
28. A.J. Duleba, B. Banaszewska, R.Z. Spaczynski, and L. Pawelczyk Success of laparoscopic ovarian wedge resection is related to obesity, lipid profile, and insulin levels Fertil Steril 79 2003 1008 1014
29. S.A. Amer, T.C. Li, and I.D. Cooke A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy Hum Reprod 18 2003 1693 1698
30. G.R. Attia, W.E. Rainey, and R.C. Bruce Metformin directly inhibits androgen production in human thecal cells Fertil Steril 76 2001 517 524
31. C.H. Wu, Y.F. Chen, J.Y. Wang, M.C. Hsieh, C.S. Yeh, and S.T. Lian Mutant K-ras oncogene regulates steroidogenesis of normal human adrenocortical cells by the RAF-MEK-MAPK pathway Br J Cancer 87 2002 1000 1005
32. C.H. Wu, S.C. Lee, H.H. Chiu, Y.C. Yang, S.T. Lian, and S.J. Shin Morphologic change and elevation of cortisol secretion in cultured human normal adrenocortical cells caused by mutant p21K-ras protein DNA Cell Biol 21 2002 21 29
33. I.J. Rzepczynska, P.C. Piotrowski, D.H. Wong, A.B. Cress, J. Villanueva, and A.J. Duleba Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat Biol Reprod 81 2009 850 855